Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Asahi Kasei Corp.

www.asahi-kasei.co.jp

Latest From Asahi Kasei Corp.

APAC Podcast: Significant Approvals, Diabetes And NASH In India, Japan M&A

Join the Asia-based content team for Scrip and the Pink Sheet for their first podcast as they take a look at some of the most significant regional pharma stories of the past few weeks.   

Asia Pacific Approvals

Asahi Paying $1.3bn For One-Product Veloxis

Diversified Japanese giant to launch tender for Danish transplant drug specialist as it looks to build US operations for health care business. Lundbeck and Novo Nordisk among investors that will see an exit.

M & A Business Strategies

Blackstone Bets On Pharma In First Japan Buy, But Why?

Major private equity group Blackstone buys into pharma for its first acquisition in Japan, but amid challenges in the sector, the attractions take some unraveling.

Japan Business Strategies

Bone Therapeutics Cracks On With Allogeneic Cells For Spinal Fusion, Broken Bones

2019 should see top-line clinical results for Bone Therapeutics' off-the-shelf cell therapy for spinal fusion procedures.

Regenerative Medicine Orthopedics
See All

Company Information

UsernamePublicRestriction

Register